Bioxytran Stock Market Value
Bioxytran's market value is the price at which a share of Bioxytran trades on a public exchange. It measures the collective expectations of Bioxytran investors about its performance. With this module, you can estimate the performance of a buy and hold strategy of Bioxytran and determine expected loss or profit from investing in Bioxytran over a given investment horizon. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in median.
| Symbol | Bioxytran |
Bioxytran 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bioxytran's otc stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bioxytran.
| 07/01/2025 |
| 12/28/2025 |
If you would invest 0.00 in Bioxytran on July 1, 2025 and sell it all today you would earn a total of 0.00 from holding Bioxytran or generate 0.0% return on investment in Bioxytran over 180 days. Bioxytran is related to or competes with Biovaxys Technology. Bioxytran, Inc., a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization... More
Bioxytran Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bioxytran's otc stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bioxytran upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.66 | |||
| Information Ratio | 0.0663 | |||
| Maximum Drawdown | 39.72 | |||
| Value At Risk | (11.13) | |||
| Potential Upside | 13.09 |
Bioxytran Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bioxytran's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bioxytran's standard deviation. In reality, there are many statistical measures that can use Bioxytran historical prices to predict the future Bioxytran's volatility.| Risk Adjusted Performance | 0.0639 | |||
| Jensen Alpha | 0.5502 | |||
| Total Risk Alpha | (0.22) | |||
| Sortino Ratio | 0.0832 | |||
| Treynor Ratio | (11.15) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bioxytran's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bioxytran Backtested Returns
Bioxytran appears to be out of control, given 3 months investment horizon. Bioxytran secures Sharpe Ratio (or Efficiency) of 0.0783, which signifies that the company had a 0.0783 % return per unit of risk over the last 3 months. By analyzing Bioxytran's technical indicators, you can evaluate if the expected return of 0.56% is justified by implied risk. Please makes use of Bioxytran's Mean Deviation of 5.12, downside deviation of 5.66, and Risk Adjusted Performance of 0.0639 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Bioxytran holds a performance score of 6. The firm shows a Beta (market volatility) of -0.049, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Bioxytran are expected to decrease at a much lower rate. During the bear market, Bioxytran is likely to outperform the market. Please check Bioxytran's maximum drawdown, as well as the relationship between the skewness and day typical price , to make a quick decision on whether Bioxytran's price patterns will revert.
Auto-correlation | -0.4 |
Poor reverse predictability
Bioxytran has poor reverse predictability. Overlapping area represents the amount of predictability between Bioxytran time series from 1st of July 2025 to 29th of September 2025 and 29th of September 2025 to 28th of December 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bioxytran price movement. The serial correlation of -0.4 indicates that just about 40.0% of current Bioxytran price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.4 | |
| Spearman Rank Test | -0.27 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Bioxytran lagged returns against current returns
Autocorrelation, which is Bioxytran otc stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bioxytran's otc stock expected returns. We can calculate the autocorrelation of Bioxytran returns to help us make a trade decision. For example, suppose you find that Bioxytran has exhibited high autocorrelation historically, and you observe that the otc stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Bioxytran regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bioxytran otc stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bioxytran otc stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bioxytran otc stock over time.
Current vs Lagged Prices |
| Timeline |
Bioxytran Lagged Returns
When evaluating Bioxytran's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bioxytran otc stock have on its future price. Bioxytran autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bioxytran autocorrelation shows the relationship between Bioxytran otc stock current value and its past values and can show if there is a momentum factor associated with investing in Bioxytran.
Regressed Prices |
| Timeline |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Bioxytran OTC Stock Analysis
When running Bioxytran's price analysis, check to measure Bioxytran's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bioxytran is operating at the current time. Most of Bioxytran's value examination focuses on studying past and present price action to predict the probability of Bioxytran's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bioxytran's price. Additionally, you may evaluate how the addition of Bioxytran to your portfolios can decrease your overall portfolio volatility.